home / stock / ctgl / ctgl news


CTGL News and Press, Citrine Global Corp

Stock Information

Company Name: Citrine Global Corp
Stock Symbol: CTGL
Market: OTC

Menu

CTGL CTGL Quote CTGL Short CTGL News CTGL Articles CTGL Message Board
Get CTGL Alerts

News, Short Squeeze, Breakout and More Instantly...

CTGL - Expected US Company Earnings on Friday, May 10th, 2024

Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...

CTGL - Expected US Company Earnings on Wednesday, March 27th, 2024

Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...

CTGL - Expected earnings - Citrine Global Corp

Citrine Global Corp (CTGL) is expected to report for quarter end 2023-12-31

CTGL - Citrine Global to acquire up to 51% of iBOT Israel Botanicals

2023-11-21 09:27:40 ET More on Citrine Global Corp. Financial information for Citrine Global Corp. For further details see: Citrine Global to acquire up to 51% of iBOT Israel Botanicals

CTGL - Citrine Global Corp. (CTGL) Announces Binding Agreement to Acquire 51% of iBOT Israel Botanicals, a Revenue-Generating Nutritional Supplements' Company with Fast-Growing Potential

Tel Aviv, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that it has signed a binding agreement to acquire up to 51% of the shares of iBOT Israel Botanicals Ltd. (iBOT) by initially acquiring 19% and an option to obtain an additional 32% of the equity ...

CTGL - Citrine Global Corp. (CTGL) Signs MOU with MyPlant Bio, Specialized in Botanical Drug Development, to Acquire 55% of MyPlant's Shares against Citrine Global Shares

Tel Aviv, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce the signing of a memorandum of understanding (MOU) with MyPlant Bio Ltd., a pioneering Israeli company that is specialized in botanical drug development and owns certain know-how and intellectual...

CTGL - Citrine Global Corp. (OTCQB: CTGL) Files Provisional Patent Application for Balancing Side Effects

Company also Announces the Introduction of GreenFeels TM Product Lines Tel Aviv, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that the Company’s subsidiary has filed a provisional patent application in the United Stat...

CTGL - Citrine Global Corp. (OTCQB: CTGL) Announced its Subsidiary Files Provisional Patent Application Targeting to Address Oral Cavity Side Effects Associated with the Use of Medicines, Treatments, Aging or an Unbalanced/Unhealthy Lifestyle

Tel Aviv, July 18, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that the Company’s subsidiary, Cannovation Center Israel Ltd, has filed a provisional patent application in the United States Patent and Trademark Office (USPTO) for the treatment, a...

CTGL - Citrine Global Corp. (OTCQB: CTGL) Announces Prof. Itamar Grotto, a World-Renowned Expert in Public Health, Joining the Company's Israeli Subsidiary Board of Directors, and Appointed as President of Green Vision Center Israel

Prof . Grotto is a world-renowned expert in public health ; formerly Associate Director General and Director of the Public Health Services of the Israeli Ministry of Health; and Former member of the Executive Board of the World Health ...

CTGL - Citrine Global CEO Issues Letter to Shareholders

Tel Aviv, April 13, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL), a plant-based wellness and pharma solutions company, today issued a Letter to Shareholders from its CEO and Chairman, Ora Elharar-Soffer. Dear Shareholders, We are glad to provide an overview of t...

Next 10